Applies to dabigatran: oral capsule
In addition to its needed effects, some unwanted effects may be caused by dabigatran. In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking dabigatran:


Applies to dabigatran: oral capsule
Bleeding is the most serious side effect reported with dabigatran.  Major or severe bleeding may occur and, regardless of location, may lead to disabling, life-threatening or even fatal outcomes.[Ref]
Major bleeds have occurred in critical areas or organs such as, intraocular, intracranial, intraspinal or intramuscular with compartment syndrome, retroperitoneal, intra-articular, or pericardial.[Ref]
Very common (10% or more): Bleeding up to 16.5%Uncommon (0.1% to 1%): Hematoma, hemorrhage[Ref]
Very common (10% or more): Dyspepsia: upper abdominal pain, abdominal discomfort, epigastric discomfort; gastritis like symptoms, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, and gastrointestinal ulcerCommon (1% to 10%): Diarrhea, nauseaUncommon (0.1% to 1%): rectal hemorrhage, hemorrhoidal hemorrhage, vomiting, dysphagiaPostmarketing reports: Esophageal ulcer[Ref]
Common (1% to 10%): Skin hemorrhagePostmarketing reports: Angioedema[Ref]
Common (1% to 10%): AnemiaUncommon (0.1% to 1%): Hemoglobin decreased, thrombocytopenia, occult blood positiveRare (less than 0.1%): Hematocrit decreased Postmarketing reports: Thrombocytopenia[Ref]
Common (1% to 10%): Wound secretion (5%)Rare (less than 0.1%): Traumatic hemorrhage[Ref]
Common (1% to 10%): Urogenital hemorrhage (including hematuria 1.2%) Uncommon (0.1% to 1%): Positive blood urine tests[Ref]
Common (1% to 10%): Epitaxis (0.6% to 0.7%)Uncommon (0.1% to 1%): Hemoptysis[Ref]
Uncommon (0.1% to 1%): Abnormal hepatic function/liver function test, ALT increased, AST increased, hepatic enzyme increasedRare (less than 0.1%): Hyperbilirubinemia, transaminases increased[Ref]
Uncommon (0.1% to 1%): Urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shockFrequency not reported: Bronchospasm[Ref]
Uncommon (0.1% to 1%): Hemarthrosis[Ref]
Uncommon (0.1% to 1%): Intracranial hemorrhageFrequency not reported: Intracerebral hemorrhage (Hemorrhagic stroke), subarachnoid and subdural bleeds[Ref]
Rare (less than 0.1%): Injection site hemorrhage, catheter site hemorrhage, incision site hemorrhage[Ref]
1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum,  Inc. "Australian Product Information." O 0
3. "Product Information. Pradaxa (dabigatran)." Boehringer-Ingelheim, Ridgefield, CT. 
4. To K,  Reynolds C,  Spinler SA "Rash associated with dabigatran etexilate." Pharmacotherapy 33 (2013): e23-7
Not all side effects for dabigatran may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Acid or sour stomach
belching
black, tarry stools
bloody stools
constipation
diarrhea
heartburn
indigestion
nausea
pain or burning in the throat
stomach discomfort, upset, burning, or pain
vomiting
vomiting of blood or material that looks like coffee grounds


Cough
difficulty with swallowing
dizziness
fainting or loss of consciousness
fast heartbeat
fast or irregular breathing
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
redness of the skin
skin rash, hives, welts, or itching skin
tightness in the chest
trouble breathing
unusual tiredness or weakness


Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

